| 000 | 01742 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517204057.0 | ||
| 264 | 0 | _c20190117 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a2107-0180 | ||
| 024 | 7 |
_a10.1007/s13318-018-0464-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHardt, Joshua I | |
| 245 | 0 | 0 |
_aPharmacokinetics and Toxicology of the Neuroprotective e,e,e-Methanofullerene(60)-63-tris Malonic Acid [C _h[electronic resource] |
| 260 |
_bEuropean journal of drug metabolism and pharmacokinetics _cOct 2018 |
||
| 300 |
_a543-554 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aFullerenes _xadministration & dosage |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHepatobiliary Elimination |
| 650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xblood |
| 650 | 0 | 4 | _aLethal Dose 50 |
| 650 | 0 | 4 |
_aMPTP Poisoning _xblood |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aRenal Elimination |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aPerlmutter, Joel S | |
| 700 | 1 | _aSmith, Christopher J | |
| 700 | 1 | _aQuick, Kevin L | |
| 700 | 1 | _aWei, Ling | |
| 700 | 1 | _aChakraborty, Subhasish K | |
| 700 | 1 | _aDugan, Laura L | |
| 773 | 0 |
_tEuropean journal of drug metabolism and pharmacokinetics _gvol. 43 _gno. 5 _gp. 543-554 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s13318-018-0464-z _zAvailable from publisher's website |
| 999 |
_c28160970 _d28160970 |
||